Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study.
Overview & Synopsis
Open access biomedical research article published in Liver Cancer.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Baseline Predictors, Prognostic Impact, and Risk Stratification of Early Progressive Disease on Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Multicenter Real-World Study. |
|---|---|
| Author / Organization | Sho T, Suda G, Abe T, Ninomiya M, Endo K, Fujiwara Y, Numao H, Igarashi G, Tsuruoka M, Iino C, Yoshida K, Sato S, Nakai M, Ohara M, Kitagataya T, Kawagishi N, Katsumi T, Maki K, Sato W, Minami S, Abe K, Fujita M, Yamamoto Y, Baba M, Meguro T, Oikawa T, Tanabe N, Ueno Y, Sakamoto N, Kuroda H, for NORTH Japan HCC study group |
| Subject & Discipline | Liver Cancer |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-54152 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |